Drug
Elismetrep
Elismetrep: highest development phase Phase 3, developed by TriGemX Bio, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- TriGemX Bio, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Elismetrep NCT07816367 | Phase 3 | Migraine |
Latest
No recent events.
Follow Elismetrep on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.